Search Menu Cart 0 €

Login

Registration Restore password

EIA Rubella IgG

EIA Rubella IgG
EAN Code: 8595635305016
Catalog number: RubG96
Package size: 96 tests
Regulatory status: IVD CE2265

Sample request

Sample ordering is possible only for registered users

If you are already registered, please log in
If you are new customer register

Contact person:

Name: Mgr. Miroslav Herczeg
Phone: +420 549 121 273
E-mail: herczeg@testlinecd.com

The immunoenzymatic assay is intended for the diagnosis, monitoring and screening of rubella infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory.

If you are already registered, please login

Request Product Export to PDF Print

Have a question?
Need a help?

Do not hesitate and call us or fill in a query form and we will contact you soon.

Description

Description:

  • Microtitre wells are coated with the purified and inactivated HPV-77 with high content of specific immuno dominant epitopes.
  • If specific antibodies are present, they bind to the antigen, are labeled by the Conjugate in the following steps and are detected by color reaction with a single component substrate (TMB-Complete).
  • The kit allows 96 tests, including controls in a split microtiter plate with color-coded strips and breakable wells.

Advantages:

  • The total assay time is about 2 hours.
  • High sensitivity and specificity of the test.
  • Kit includes CUT-OFF, Positive Control, Negative Control and Calibrators (1, 10, 50, 200 IU/ml).
  • Semi-quantitative evaluation in the Index of Positivity (IP) or quantitative evaluation in IU/ml.
  • Ready-to-use, color-coded components.
  • Single-component substrate.
  • Interchangeable components with the exception of kit specific components (Controls, Conjugate, Plate).
  • The kit contains the Avidity solution, which enables quantitative determination of bond strength of an antibody antigen complex. Based on this fact, it is possible to distinguish between acute and chronic phase of the disease.

Application:

  • Screening test for the detection of specific IgG antibodies in human serum or plasma.
  • Checking of therapy results using the quantitative determination.
  • Disease phase diagnostics.

Brief assay procedure:

  1. Dilute samples (1:101).
  2. Pipette Controls and diluted Samples.
  3. Incubate at 37°C for 30 min.
  4. Aspirate and wash the wells 5×
  5. Pipette Conjugate.
  6. Incubate at 37°C for 30 min.
  7. Aspirate and wash the wells 5×
  8. Pipette Substrate (TMB-Complete).
  9. Incubate at 37°C for 30 min.
  10. Pipette Stop Solution.
  11. Read color intensity at 450 nm.
  12. Evaluate the test.
Download

Have a question?
Need a help?

Mgr. Miroslav Herczeg

+420 549 121 273 herczeg@testlinecd.com